Establishing a general biosynthetic
scheme for natural products
is critical for a broader understanding of natural product biosynthesis
and the structural prediction of metabolites based on genome sequence
information. High-carbon sugar nucleoside antimicrobials are an underexplored
class of natural products with unique structures and important biological
activities. Recent studies on C6 sugar nucleoside antifungal natural
products, such as nikkomycins and polyoxins, revealed a novel biosynthetic
mechanism involving cryptic phosphorylation. However, the generality
of this biosynthetic mechanism remained unexplored. We here report
in vitro characterization of the biosynthesis of a C7 sugar nucleoside
antifungal, malayamycin A. Our results demonstrate that the malayamycin
biosynthetic enzymes specifically accept 2′-phosphorylated
biosynthetic intermediates, suggesting that cryptic phosphorylation-mediated
biosynthesis is conserved beyond C6 sugar nucleosides. Furthermore,
the results suggest a generalizable divergent biosynthetic mechanism
for high-carbon sugar nucleoside antifungals. In this model, C6 and
C7 sugar nucleoside biosyntheses proceed via a common C8 sugar nucleoside
precursor, and the sugar size is determined using the functions of
α-ketoglutarate (α-KG)-dependent dioxygenases (NikI/PolD
for C6 sugar nucleosides and MalI for C7 sugar nucleosides). These
results provide an important guidance for the future genome-mining
discovery of high-carbon sugar nucleoside antimicrobials.